SAUHY Stock | | | USD 12.99 0.20 1.56% |
CEO
Mr. Matthias Schupp was Member of the Executive Management Board, Head Sales Latin America and Chief Executive Officer of Neodent at Straumann Holding Ltd since 2016. He joined Straumann from Procter Gamble in 2007 as Regional Manager, Western Europe. In 2013, he was appointed Head of Sales for the LATAM region and joined the management of Neodent, of which he became Chief Executive Officer early in 2015. Mr Schupp has a track record in country regional management in various industries. He began his career in marketing and customer service with Merck KGaA, the German pharmaceuticals, fine chemicals and diagnostics company, and rose through country management to the position of Regional Manager Latin America and United States. He moved to Wella in 2000 as Managing Director of the business in Russia and became Managing Director Professional Care Portugal in 2004, following the acquisition of Wella by P G. Having graduated at the German Brasilian High School in Rio de Janeiro, he gained most of his training in Business Administration and Management on the job through managerial and professional development programs at Merck and P G. since 2016.
Age | 59 |
Tenure | 8 years |
Phone | 41 61 965 11 11 |
Web | https://www.straumann.com |
Straumann Holding Management Efficiency
The company has return on total asset
(ROA) of
0.1222 % which means that it generated a profit of $0.1222 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.3141 %, meaning that it generated $0.3141 on every $100 dollars invested by stockholders. Straumann Holding's management efficiency ratios could be used to measure how well Straumann Holding manages its routine affairs as well as how well it operates its assets and liabilities.
Straumann Holding AG has accumulated 479.84
M in total debt with debt to equity ratio
(D/E) of 0.4, which is about average as compared to similar companies. Straumann Holding has a current ratio of 2.78, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Straumann Holding until it has trouble settling it off, either with new capital or with free cash flow. So, Straumann Holding's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Straumann Holding sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Straumann to invest in growth at high rates of return. When we think about Straumann Holding's use of debt, we should always consider it together with cash and equity.
Similar Executives
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland. Straumann Hld operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 9883 people. Straumann Holding AG [SAUHY] is a
Pink Sheet which is traded between brokers as part of OTC trading.
Management Performance
Straumann Holding Leadership Team
Elected by the shareholders, the Straumann Holding's board of directors comprises two types of representatives: Straumann Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Straumann. The board's role is to monitor Straumann Holding's management team and ensure that shareholders' interests are well served. Straumann Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Straumann Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Holger Haderer, Head Board | |
| KokKien Loh, Head Board | |
| Wolfgang Becker, Member of the Management Board, Head Sales Central Europe | |
| Aurelio Sahagun, Head Board | |
| Matthias Schupp, Member of the Executive Management Board, Head Sales Latin America, CEO of Neodent | |
| Camila Finzi, Head Management | |
| Peter Hackel, CFO, Member of the Management Board | |
| Alastair Robertson, Head Board | |
| Rahma Samow, Head Board | |
| Guillaume Daniellot, Executive Vice President of Sales North America, Member of the Executive Management Board | |
Straumann Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Straumann Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Straumann Pink Sheet Analysis
When running Straumann Holding's price analysis, check to
measure Straumann Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Straumann Holding is operating at the current time. Most of Straumann Holding's value examination focuses on studying past and present price action to
predict the probability of Straumann Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Straumann Holding's price. Additionally, you may evaluate how the addition of Straumann Holding to your portfolios can decrease your overall portfolio volatility.